Nasdaq: BLTE

Belite Bio, Inc. (BLTE)

Belite Bio, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker BLTE. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
BLTE
Exchange
Nasdaq
SEC CIK
1889109
Official filings
SEC EDGAR

Research BLTE

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Belite Bio, Inc.'s stock ticker?

Belite Bio, Inc. trades under the ticker symbol BLTE on Nasdaq. Its SEC Central Index Key (CIK) is 1889109.

Where can I read Belite Bio, Inc.'s SEC filings?

The BLTE SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Belite Bio, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze BLTE's financial statements?

The BLTE Financials page shows Belite Bio, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does BLTE compare with its peers and the market?

The BLTE Peer Comparison page lines Belite Bio, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.